Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities

International Journal of Drug Policy

Volumn 22, Issue 2, 2011, Pages 145-152

  Nasir, Abdul ^a   Todd, Catherine S ^b   Stanekzai, M Raza ^a   Bautista, Christian T ^c   Botros, Boulos A ^d   Scott, Paul T ^c   Strathdee, Steffanie A ^e   Tjaden, Jeffrey ^d  

^a INTERNATIONAL RESCUE COMMITTEE   (Afghanistan)

^b Howard Hughes Medical Institute   (United States)

^c US Military HIV Research Program   (United States)

^d US Naval Medical Research Unit No 3 Egypt   (Egypt)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Afghanistan; Hepatitis B; Hepatitis C; HIV; Injecting drug users

Indexed keywords

ANTIRETROVIRUS AGENT; DIAMORPHINE; HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY; PENTAZOCINE; PHENIRAMINE AMINOSALICYLATE;

ADULT; AFGHANISTAN; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PRISON; SEXUAL BEHAVIOR; VIRUS TRANSMISSION; ATTITUDE TO HEALTH; CHI SQUARE DISTRIBUTION; DISEASE TRANSMISSION; DRUG USE; HEALTH BEHAVIOR; INTERVIEW; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; SUBSTANCE ABUSE; UNSAFE SEX; URBAN POPULATION;

ADULT; AFGHANISTAN; CHI-SQUARE DISTRIBUTION; DRUG USERS; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MALE; NEEDLE SHARING; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX; URBAN POPULATION; YOUNG ADULT;

EID: 79960988208     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.10.008     Document Type: Article

References (34)

1. Achakzai M., Kassi M., Kasi P.M. Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan. Tropical Doctor 2007, 37:43-45.
2. Bari A., Akhtar S., Rahbar M.H., Luby S.P. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Tropical Medicine & International Health 2001, 6:732-738.
3. Central Statistics Organization, Afghanistan. Census. (2010). Available at Accessed 27.07.2010. http://www.cso.gov.af/index.html.
4. Emmanuel F., Archibald C., Razaque A., Sandstrom P. Factors associated with an explosive HIV epidemic among injecting drug users in Sargodha, Pakistan. Journal of Acquired Immune Deficiency Syndrome. 2009, 51:85-90.
5. European Monitoring Centre for Drugs and Drug Addiction Technical data sheets: Monitoring the supply of heroin to Europe 2008, Office for Official Publications of the European Communities, Luxembourg. 10.2810/44004.
6. Griffin N., Khoshnood K. Opium trade, insurgency, and HIV/AIDS in Afghanistan: Relationships and regional consequences. Asia Pacific Journal of Public Health 2010, 22:159S-167S.
7. Gyarmathy V.A., Neaigus A., Mitchell M.M., Ujhelyi E. The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary. Drug and Alcohol Dependence 2009, 100:240-247.
8. Hankins C.A., Friedman S.R., Zafar T., Strathdee S.A. Transmission and prevention of HIV and sexually transmitted infections in war settings: Implications for current and future armed conflicts. AIDS 2002, 16:2245-2252.
9. Hickman M., Hope V., Brady T., Madden P., Jones S., Honor S., et al. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. Journal of Viral Hepatitis 2007, 14:645-652.
10. Holtzman D, Barry V., Ouellet L.J., DesJarlais D.C., Vlahov D., Golub E.T., et al. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Preventive Medicine 2009, 49:68-73.
11. Joint United Nations Programme on HIV/AIDS (UNAIDS) Report on the global AIDS epidemic 2008, UNAIDS, Geneva, Switzerland.
12. Joyce R. Thousands of Afghans forced home from Iran 2007, May, Reuters News Service, Retrieved from http://www.reuters.com/article/idUSSP23521020070508.
13. Knott, L. (2008, December 1) UNICEF - Afghanistan - Children at risk of contracting HIV/AIDS in Afghanistan. Available at: http://www.unicef.org/infobycountry/afghanistan_46717.html.
14. Kuo I., ul-Hasan S., Galai N., Thomas D.L., Zafar T., Ahmed M.A., et al. High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. Harm Reduction Journal 2006, 3:26.
15. Lee K.C., Lim W.W., Lee S.S. High prevalence of HCV in a cohort of injectors on methadone substitution treatment. Journal of Clinical Virology 2008, 41:297-300.
16. Leung Y., Chan J.I., Yoshida E., Wu H.X., Daly P.C. A cross-sectional analysis of acute hepatitis B virus reported to the Vancouver Coastal Health Authority from 2000 to 2003. Canadian Journal of Gastroenterology 2006, 20:471-474.
17. MacDonald D. Afghanistan research and evaluation unit briefing paper series: Afghanistan's hidden drug problem: The misuse of psychotropics 2008, AREU, Kabul, Afghanistan.
18. Medić A., Dzelalija B., Sonicki Z., Zekanović D. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia. Collegium Antropologicum 2008, 32:697-702.
19. National AIDS Control Program, Ministry of Public Health, Islamic Republic of Afghanistan UNGASS country progress report: Afghanistan 2010, Ministry of Public Health, Kabul, Afghanistan.
20. Razzaghi E., Nassirirmanesh B., Afshar B., Ohiri K., Claeson M., Power R. HIV/AIDS harm reduction in Iran. Lancet 2006, 368:434-435.
21. Sanchez J.L., Todd C.S., Bautista C.T., Botros B.A., Khakimov M.M., Giyasova G.M., et al. High HIV prevalence and risk factors among injecting drug users in Tashkent, Uzbekistan, 2003-04. Drug & Alcohol Dependence 2006, 82(Suppl. 1):S15-22.
22. Stachowiak J.A., Tishkova F.K., Strathdee S.A., Stibich M.A., Latypov A., Mogilnii V., et al. Marked ethnic differences in HIV prevalence and risk behaviors among injection drug users in Dushanbe, Tajikistan, 2004. Drug & Alcohol Dependence 2006, 82(Suppl. 1):S7-14.
23. Stein J.A., Nyamathi A. Correlates of hepatitis C virus infection in homeless men: A latent variable approach. Drug & Alcohol Dependence 2004, 75:89-95.
24. Sunthornchart S., Linkins R.W., Natiphisarnwanish V., Levine W.C., Maneesinthu K., Lolekha R., et al. Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus, and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005. Addiction 2008, 103:1687-1695.
25. Todd C.S., Abed A.M., Strathdee S.A., Scott P.T., Botros B.A., Safi N., et al. Prevalence of HIV, hepatitis C, hepatitis B, and associated risk behaviors among injection drug users in Kabul, Afghanistan. Emerging Infectious Diseases 2007, 13:1327-1331.
26. Todd C.S., Nasir A., Stanekzai M.R., Bautista C.T., Botros B.A., Scott P.T., et al. HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities. AIDS 2010, 24(Suppl 2):S69-S76.
27. United Nations High Commission on Refugees (UNHCR) (2006, June 9). UNHCR global refugee tally at 26-year low while internally displaced increase. Retrieved October, 2010 from: http://www.unhcr.org/news/NEWS/4489294f4.html.
28. United Nations Office on Drugs and Crime (UNODC) Afghanistan drug use survey 2005 2005, UNODC, Kabul, Afghanistan.
29. United Nations Office on Drugs and Crime (UNODC) World drug report 2007 2007, United Nations Publications, Slovakia.
30. United Nations Office on Drugs and Crime (UNODC) Afghanistan opium survey 2008: Executive summary 2008, UNODC, Kabul, Afghanistan.
31. United Nations Office on Drugs and Crime (UNODC) Drug use in Afghanistan: 2009 survey. Executive summary 2010, UNODC, Kabul, Afghanistan.
32. Zamani S., Kihara M., Gouya M.M., Vazirian M., Nassirimanesh B., Ono-Kihara M., et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. Journal of Acquired Immune Deficiency Syndrome 2006, 42:342-346.
33. Zamani S., Kihara M., Gouya M.M., Vazirian M., Ono-Kihara M., Razzaghi E.M., et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS 2005, 19:709-716.
34. Zamani S., Ichikawa S., Nassirimanesh B., Vazirian M., Ichikawa K., Gouya M.M., et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. International Journal of Drug Policy 2007, 18:359-363.